🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Germ Cell Cancer Metastatic

Evaluation of Hypoxia in Primary Melanoma NCT06831071n/a1 site📍 Pittsburgh Yana Najjar · Tests: Pimonidazole Naltrexone and Propranolol Combined With Immunotherapy NCT05968690Phase 11 site📍 New Brunswick Sarah Weiss · Tests: Propranolol, Naltrexone NK Cell Therapy for Malignant Solid Brain Tumors NCT07552233NA4 sites📍 Beijing📍 Qinhuangdao📍 Zhengzhou Peking University Third Hospital · Tests: Autologous NK cells Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis NCT07203391Phase 12 sites📍 Sydney📍 Melbourne St Vincent's Hospital, Sydney · Tests: roginolisib An Experimental Study of Belzutifan Impact on Catecholamine Metabolism NCT07680205Phase 21 site📍 Cambridge Cambridge University Hospitals NHS Foundation Trust · Tests: Belzutifan Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker Decline NCT07847190Phase 21 site📍 Moscow Blokhin's Russian Cancer Research Center · Tests: Paclitaxel, Bleomycin, Etoposide, Cisplatin, G-CSF (Filgrastim) A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab NCT02621021Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: young TIL, Pembrolizumab, Aldesleukin, Fludarabine, Cyclophosphamide A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan Tebentafusp-tebn With LDT in Metastatic UM NCT06626516Phase 1, Phase 21 site📍 Philadelphia Thomas Jefferson University · Tests: Tebentafusp-Tebn, GM-CSF (Sargramostim), BCNU Imaging of Solid Tumors Using 18F-TRX NCT06942104Phase 11 site📍 San Francisco Rahul Aggarwal · Tests: 18F-TRX, Positron Emission Tomography (PET)/Computerized tomography (CT), Tumor Biopsy, Blood Specimen Collection Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade NCT07130032Phase 21 site📍 Saint Petersburg EuroCityClinic LLC · Tests: reICB regimen (NSCLC), reICB regimen (melanoma) Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer NCT07664579n/a1 site📍 Duarte City of Hope Medical Center · Tests: Non-Interventional Study Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma NCT07136181Phase 1, Phase 23 sites📍 Scottsdale📍 Denver📍 Nashville Novelwise Pharmaceutical Corporation · Tests: NBM-BMX Capsule are proprietary products developed by Novelwise Pharmaceutical Corporation (Novelwise) for treatment of… A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites📍 Aurora📍 Lake Mary📍 Lebanon 7 Hills Pharma, LLC · Tests: Alintegimod, Ipilimumab, Nivolumab Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma NCT07057596Phase 24 sites📍 Berlin📍 L'Hospitalet de Llobregat📍 Madrid Grupo Español Multidisciplinar de Melanoma · Tests: Tebentafusp Mirdametinib in Patients With Advanced NF1-mutant Melanoma NCT07237100Phase 21 site📍 San Francisco Kevin Kim, MD · Tests: Mirdametinib Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma NCT04697576Phase 11 site📍 Columbus Carlo Contreras · Tests: Ipilimumab, Nivolumab, Pembrolizumab, Quadrivalent Inactivated Influenza Vaccine, Resection A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites📍 Grand Rapids📍 St Louis📍 Pittsburgh AstraZeneca · Tests: AZD6750, rilvegostomig Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases NCT03093909Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Gemcitabine Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial NCT07155317Phase 22 sites📍 Atlanta📍 Atlanta Emory University · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Magnetic Resonance Imaging Lutathera and ASTX727 in Neuroendocrine Tumours NCT05178693Phase 11 site📍 London Imperial College London · Tests: ASTX727, Lutathera Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma NCT07276386Phase 21 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Melphalan/HDS (Percutaneous Hepatic Perfusion), Tebentafusp A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors NCT04794972Phase 16 sites📍 Beijing📍 Chongqing📍 Guangzhou Sichuan Baili Pharmaceutical Co., Ltd. · Tests: GNC-039 Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis NCT07281924Phase 1, Phase 21 site📍 Madison University of Wisconsin, Madison · Tests: Nivolumab and Relatlimab, Melphalan Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors NCT07584499Phase 11 site📍 Guangzhou Sun Yat-sen University · Tests: Becotatug Vedotin Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma NCT00107289Phase 21 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: iobenguane I 131 EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors NCT05970497Phase 1, Phase 215 sites📍 Los Angeles📍 Rancho Santa Margarita📍 Weston Krystal Biotech, Inc. · Tests: KB707, Opdualag, KEYTRUDA ®( Pembrolizumab) TIL Therapy in cSCC and MCC NCT07288073Phase 21 site📍 Boston Karam Khaddour, MD, MS · Tests: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2 Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases NCT05704647Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy